...
Target tumors are measured in the longest diameter except when the location is a lymph node, then they are measured in the short axis (i.e., longest perpendicular measurement). The examples in this disease response supplement use TRTESTCD = "LDIAM" (Longest Diameter) for measurements of non-lymph node target tumors and TRTESTCD = "LPERP" (Longest Perpendicular) for measurements in the short axis longest perpendicular of lymph node target tumors. The SDTMIG examples have previously used TRTESTCD = "DIAMETER" (Diameter) for measurements of both lymph nodes and non-lymph nodes. Either representation is acceptable for RECIST 1.1. The latter approach requires looking at the anatomical location in conjunction with the TRTESTCD to know whether the diameter was measured in the longest diameter or the short axislongest perpendicular. The "LDIAM" and "LPERP" tests provide more specificity in the TRTESTCD itself and does not required looking to the anatomical location. In addition, "LDIAM" and "LPERP" are tests used in other disease response criteria so the use of these two tests provides standardization that work across criteria for the same measurement. Some sponsors prefer the approach used within this disease response supplement due to these reasons.
...
The tu.xpt table below shows the terminology used to implement RECIST 1.1 in the TU domain. This example shows the data for one subject at screening and at weeks 36 and 44 where new lesions are identified. In this example, lymph nodes are selected as target tumors. In RECIST 1.1, target lymph node tumors are measured in the short axis longest perpendicular (TRTESTCD = "LPERP" and TRTEST = "Longest Perpendicular") in the TR domain. The image identifier is in TUREFID and matches a PRREFID in the PR Domain.
...
The tr.xpt table below shows the terminology used to implement RECIST 1.1 in the TR domain. This example shows the data for one subject collected at screening, week 6, week 12 and subsequent 8-week follow-up visits. It The example below shows measurements of lymph nodes, (i.e., longest perpendicular (measured in the short axis), ) of lymph nodes as well as measurements of other non-lymph node Target tumors , (i.e., longest diameter). In this example, when TRTEST = "Lymph Node State" and TRORRES = "NON-PATHOLOGICAL", it indicates that the lymph node lesion was not pathological, i.e. the diameter has reduced below 10mm. The assessment of a lymph node tumor is less than 10mm. When a target lymph node tumor has longest perpendicular greater than or equal to 10mm, the assessment is represented with TRTEST = "Lymph Node State" and TRORRES = "NON-PATHOLOGICAL" when that all target lymph node lesions have short axis less than 10mm or TRORRES = "PATHOLOGICAL" when at least one target lymph node tumor has short axis greater than or equal to 10mm. The image identifier is in TRREFID and matches a PRREFID in the PR Domain.
Dataset wrap |
---|
|
Rowcaps |
---|
Rows 1-6: Show the screening identification screening assessments of the target and non-target lesions. For lymph node target lesions "T01" and "T02" the TRTESTCD used for the assessments are "LPREP" and "LNSTATE". For non-lymph node target lesions,"T03" and "T04", the TRTESTCD used for the assessments is "LDIAM". Rows 7-8: Show the results for the non-targets. "NT01" is a lymph node where the TRTEST used for the assessments is "Lymph Node State" (TRTESTCD = "LNSTATE"). "NT02" is a non-lymph node where the TRTEST used for the assessments is "Tumor State" (TRTESTCD = "TUMSTATE"). Row 14: Shows a case where the scan was not performed at week 6 (for TRTEST = "Longest Diameter", TRSTAT = "NOT DONE" with TRREASND = "SCAN NOT PERFORMED"). Row 15: Shows a case where the non-target "NT01" was not evaluable (for TRTEST = "Lymph Node State", TRSTAT = "NOT DONE" with TRREASND = "NOT EVALUABLE"). Row 16: Shows a case where the non-target "NT02" was not evaluable (for TRTEST = "Tumor State", TRSTAT = "NOT DONE" with TRREASND = "NOT ASSESSABLE: Image obscured"). Row 30: Shows a target lesion "T04" which is too small to measure. The TRORRES = "TOO SMALL TO MEASURE", and the TRSTRESC and TRSTRESN are standardized to "5" with TRSTRESU as "mm". The standardized value of "5" ensures that the sum of diameters includes a value for that lesion because it has not disappeared. Providing this The method of standardization of the TRSTRESC and TRSTRESN values is sponsor specific. Row 58: Shows a new lesion "NEW01" which has a measurement of 4 mm. Note that this value is less than 5 mm and has not been reported as "TOO SMALL TO MEASURE". |
Dataset2 |
---|
Row | STUDYID | DOMAIN | USUBJID | TRSEQ | TRGRPID | TRREFID | TRLNKGRP | TRLNKID | TRTESTCD | TRTEST | TRORRES | TRORRESU | TRSTRESC | TRSTRESN | TRSTRESU | TRSTAT | TRREASND | TRMETHOD | TREVAL | EPOCH | VISITNUM | VISIT | TRDTC | TRDY | 1 | EX11111 | TR | 90001 | 1 | TARGET | IMG-00001 | A1 | T01 | LPERP | Longest Perpendicular | 17 | mm | 17 | 17 | mm |
|
| MRI | INVESTIGATOR | SCREEN | 10 | SCREENING | 2010-01-01 | -3 | 2 | EX11111 | TR | 90001 | 2 | TARGET | IMG-00001 | A1 | T01 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| MRI | INVESTIGATOR | SCREEN | 10 | SCREENING | 2010-01-01 | -3 | 3 | EX11111 | TR | 90001 | 3 | TARGET | IMG-00002 | A1 | T02 | LPERP | Longest Perpendicular | 16 | mm | 16 | 16 | mm |
|
| CT SCAN | INVESTIGATOR | SCREEN | 10 | SCREENING | 2010-01-02 | -2 | 4 | EX11111 | TR | 90001 | 4 | TARGET | IMG-00002 | A1 | T02 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | SCREEN | 10 | SCREENING | 2010-01-02 | -2 | 5 | EX11111 | TR | 90001 | 5 | TARGET | IMG-00001 | A1 | T03 | LDIAM | Longest Diameter | 15 | mm | 15 | 15 | mm |
|
| MRI | INVESTIGATOR | SCREEN | 10 | SCREENING | 2010-01-01 | -3 | 6 | EX11111 | TR | 90001 | 6 | TARGET | IMG-00003 | A1 | T04 | LDIAM | Longest Diameter | 14 | mm | 14 | 14 | mm |
|
| PHOTOGRAPHY | INVESTIGATOR | SCREEN | 10 | SCREENING | 2010-01-03 | -1 | 7 | EX11111 | TR | 90001 | 7 | NON-TARGET | IMG-00002 | A1 | NT01 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | SCREEN | 10 | SCREENING | 2010-01-02 | -2 | 8 | EX11111 | TR | 90001 | 8 | NON-TARGET | IMG-00001 | A1 | NT02 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| MRI | INVESTIGATOR | SCREEN | 10 | SCREENING | 2010-01-01 | -3 | 9 | EX11111 | TR | 90001 | 9 | TARGET | IMG-00004 | A2 | T01 | LPERP | Longest Perpendicular | 12 | mm | 12 | 12 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-15 | 43 | 10 | EX11111 | TR | 90001 | 10 | TARGET | IMG-00004 | A2 | T01 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-15 | 43 | 11 | EX11111 | TR | 90001 | 11 | TARGET | IMG-00005 | A2 | T02 | LPERP | Longest Perpendicular | 12 | mm | 12 | 12 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-16 | 44 | 12 | EX11111 | TR | 90001 | 12 | TARGET | IMG-00005 | A2 | T02 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-16 | 44 | 13 | EX11111 | TR | 90001 | 13 | TARGET | IMG-00004 | A2 | T03 | LDIAM | Longest Diameter | 14 | mm | 14 | 14 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-15 | 43 | 14 | EX11111 | TR | 90001 | 14 | TARGET |
| A2 | T04 | LDIAM | Longest Diameter |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | PHOTOGRAPHY | INVESTIGATOR | TREATMENT | 40 | WEEK 6 |
|
| 15 | EX11111 | TR | 90001 | 15 | NON-TARGET | IMG-00005 | A2 | NT01 | LNSTATE | Lymph Node State |
|
|
|
|
| NOT DONE | NOT EVALUABLE | CT SCAN | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-16 | 44 | 16 | EX11111 | TR | 90001 | 16 | NON-TARGET | IMG-00004 | A2 | NT02 | TUMSTATE | Tumor State |
|
|
|
|
| NOT DONE | NOT ASSESSABLE: Image obscured | MRI | INVESTIGATOR | TREATMENT | 40 | WEEK 6 | 2010-02-15 | 43 | 17 | EX11111 | TR | 90001 | 17 | TARGET | IMG-00007 | A3 | T01 | LPERP | Longest Perpendicular | 12 | mm | 12 | 12 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-29 | 85 | 18 | EX11111 | TR | 90001 | 18 | TARGET | IMG-00007 | A3 | T01 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-29 | 85 | 19 | EX11111 | TR | 90001 | 19 | TARGET | IMG-00008 | A3 | T02 | LPERP | Longest Perpendicular | 12 | mm | 12 | 12 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-30 | 86 | 20 | EX11111 | TR | 90001 | 20 | TARGET | IMG-00008 | A3 | T02 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-30 | 86 | 21 | EX11111 | TR | 90001 | 21 | TARGET | IMG-00007 | A3 | T03 | LDIAM | Longest Diameter | 15 | mm | 15 | 15 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-29 | 85 | 22 | EX11111 | TR | 90001 | 22 | TARGET | IMG-00009 | A3 | T04 | LDIAM | Longest Diameter | 8 | mm | 8 | 8 | mm |
|
| PHOTOGRAPHY | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-04-01 | 87 | 23 | EX11111 | TR | 90001 | 23 | NON-TARGET | IMG-00008 | A3 | NT01 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-30 | 86 | 24 | EX11111 | TR | 90001 | 24 | NON-TARGET | IMG-00007 | A3 | NT02 | TUMSTATE | Tumor State |
|
|
|
|
| NOT DONE | NOT ASSESSABLE: Image obscured | MRI | INVESTIGATOR | TREATMENT | 60 | WEEK 12 | 2010-03-29 | 85 | 25 | EX11111 | TR | 90001 | 25 | TARGET | IMG-00010 | A4 | T01 | LPERP | Longest Perpendicular | 9 | mm | 9 | 9 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-27 | 144 | 26 | EX11111 | TR | 90001 | 26 | TARGET | IMG-00010 | A4 | T01 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-27 | 144 | 27 | EX11111 | TR | 90001 | 27 | TARGET | IMG-00011 | A4 | T02 | LPERP | Longest Perpendicular | 12 | mm | 12 | 12 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-28 | 145 | 28 | EX11111 | TR | 90001 | 28 | TARGET | IMG-00011 | A4 | T02 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-28 | 145 | 29 | EX11111 | TR | 90001 | 29 | TARGET | IMG-00010 | A4 | T03 | LDIAM | Longest Diameter | 11 | mm | 11 | 11 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-27 | 144 | 30 | EX11111 | TR | 90001 | 30 | TARGET | IMG-00012 | A4 | T04 | LDIAM | Longest Diameter | TOO SMALL TO MEASURE | mm | 5 | 5 | mm |
|
| PHOTOGRAPHY | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-30 | 147 | 31 | EX11111 | TR | 90001 | 31 | NON-TARGET | IMG-00011 | A4 | NT01 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-28 | 145 | 32 | EX11111 | TR | 90001 | 32 | NON-TARGET | IMG-00010 | A4 | NT02 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 80 | WEEK 20 | 2010-05-27 | 144 | 33 | EX11111 | TR | 90001 | 33 | TARGET | IMG-00013 | A5 | T01 | LPERP | Longest Perpendicular | 9 | mm | 9 | 9 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-23 | 201 | 34 | EX11111 | TR | 90001 | 34 | TARGET | IMG-00013 | A5 | T01 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-23 | 201 | 35 | EX11111 | TR | 90001 | 35 | TARGET | IMG-00014 | A5 | T02 | LPERP | Longest Perpendicular | 8 | mm | 8 | 8 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-24 | 202 | 36 | EX11111 | TR | 90001 | 36 | TARGET | IMG-00014 | A5 | T02 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-24 | 202 | 37 | EX11111 | TR | 90001 | 37 | TARGET | IMG-00013 | A5 | T03 | LDIAM | Longest Diameter | 6 | mm | 6 | 6 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-23 | 201 | 38 | EX11111 | TR | 90001 | 38 | TARGET | IMG-00015 | A5 | T04 | LDIAM | Longest Diameter | 0 | mm | 0 | 0 | mm |
|
| PHOTOGRAPHY | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-25 | 203 | 39 | EX11111 | TR | 90001 | 39 | NON-TARGET | IMG-00014 | A5 | NT01 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-24 | 202 | 40 | EX11111 | TR | 90001 | 40 | NON-TARGET | IMG-00013 | A5 | NT02 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 100 | WEEK 28 | 2010-07-23 | 201 | 41 | EX11111 | TR | 90001 | 41 | TARGET | IMG-00016 | A6 | T01 | LPERP | Longest Perpendicular | 8 | mm | 8 | 8 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 42 | EX11111 | TR | 90001 | 42 | TARGET | IMG-00016 | A6 | T01 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 43 | EX11111 | TR | 90001 | 43 | TARGET | IMG-00017 | A6 | T02 | LPERP | Longest Perpendicular | 9 | mm | 9 | 9 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 44 | EX11111 | TR | 90001 | 44 | TARGET | IMG-00017 | A6 | T02 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 45 | EX11111 | TR | 90001 | 45 | TARGET | IMG-00016 | A6 | T03 | LDIAM | Longest Diameter | 0 | mm | 0 | 0 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 46 | EX11111 | TR | 90001 | 46 | TARGET | IMG-00018 | A6 | T04 | LDIAM | Longest Diameter | 0 | mm | 0 | 0 | mm |
|
| PHOTOGRAPHY | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 47 | EX11111 | TR | 90001 | 47 | NON-TARGET | IMG-00017 | A6 | NT01 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 48 | EX11111 | TR | 90001 | 48 | NON-TARGET | IMG-00016 | A6 | NT02 | TUMSTATE | Tumor State | ABSENT |
| ABSENT |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 49 | EX11111 | TR | 90001 | 49 | NEW | IMG-00017 | A6 | NEW01 | TUMSTATE | Tumor State | EQUIVOCAL |
| EQUIVOCAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 120 | WEEK 36 | 2010-09-17 | 257 | 50 | EX11111 | TR | 90001 | 50 | TARGET | IMG-00019 | A7 | T01 | LPERP | Longest Perpendicular | 12 | mm | 12 | 12 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-15 | 314 | 51 | EX11111 | TR | 90001 | 51 | TARGET | IMG-00019 | A7 | T01 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-15 | 314 | 52 | EX11111 | TR | 90001 | 52 | TARGET | IMG-00020 | A7 | T02 | LPERP | Longest Perpendicular | 9 | mm | 9 | 9 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-14 | 313 | 53 | EX11111 | TR | 90001 | 53 | TARGET | IMG-00020 | A7 | T02 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-14 | 313 | 54 | EX11111 | TR | 90001 | 54 | TARGET | IMG-00019 | A7 | T03 | LDIAM | Longest Diameter | 0 | mm | 0 | 0 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-15 | 314 | 55 | EX11111 | TR | 90001 | 55 | TARGET | IMG-00021 | A7 | T04 | LDIAM | Longest Diameter | 0 | mm | 0 | 0 | mm |
|
| PHOTOGRAPHY | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-16 | 315 | 56 | EX11111 | TR | 90001 | 56 | NON-TARGET | IMG-00020 | A7 | NT01 | LNSTATE | Lymph Node State | NON-PATHOLOGICAL |
| NON-PATHOLOGICAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-15 | 314 | 57 | EX11111 | TR | 90001 | 57 | NON-TARGET | IMG-00019 | A7 | NT02 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-14 | 313 | 58 | EX11111 | TR | 90001 | 58 | NEW | IMG-00020 | A7 | NEW01 | LDIAM | Longest Diameter | 4 | mm | 4 | 4 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-15 | 314 | 59 | EX11111 | TR | 90001 | 59 | NEW | IMG-00020 | A7 | NEW01 | TUMSTATE | Tumor State | UNEQUIVOCAL |
| UNEQUIVOCAL |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-15 | 314 | 60 | EX11111 | TR | 90001 | 60 | NEW | IMG-00019 | A7 | NEW02 | LDIAM | Longest Diameter | 7 | mm | 7 | 7 | mm |
|
| MRI | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-14 | 313 | 61 | EX11111 | TR | 90001 | 61 | NEW | IMG-00019 | A7 | NEW02 | TUMSTATE | Tumor State | UNEQUIVOCAL |
| UNEQUIVOCAL |
|
|
|
| MRI | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-14 | 313 | 62 | EX11111 | TR | 90001 | 62 | NEW | IMG-00022 | A7 | NEW03 | LNSTATE | Lymph Node State | PATHOLOGICAL |
| PATHOLOGICAL |
|
|
|
| ULTRASOUND | INVESTIGATOR | TREATMENT | 140 | WEEK 44 | 2010-11-15 | 315 | |
|
...
The tr.xpt table below shows the terminology used to implement RECIST 1.1 in the TR domain. This example shows the data for one subject collected at screening, week 6 and subsequent 8-week follow-up visits. The example shows the preferred representation of split (fragmented) and merged (coalesced) tumors. This preferred approach provides transparent with traceability with parent lesions. This example shows how to represent data on a single row when a target tumor becomes too small to measure. In terms of RECIST 1.1, the original results would be "TOO SMALL TO MEASURE" and the standard results (TRSTRESN and TRSTRESC) would be "5". In addition, the example represents a situations situation where a result was not provided because the image was obscured and the tumor was not assessable.
This examples example shows that a situation where the Investigator provided the summary values for Target for Target lesions as a group (TRGRPID = "TARGET"). The TRTESTCD = "SUMDIAM" is used for the assessments. Note Note that the sponsor should not derived these values if they were not part of the data capture.
...
The tr.xpt table below shows the terminology used to implement RECIST 1.1 in the TR domain. This example also shows a case were progressive disease due to symptomatic deterioration was determined based on a clinical assessment by the investigator. In addition, the example represents a situations situation where a result was not provided because the scan was not performed.
Dataset wrap |
---|
|
Rowcaps |
---|
Rows 1-32: Show RECIST 1.1 assessments of target and non-target lesions at screening, week 8, week 16 and week 24. Rows 33-39: Show that the scans of target and non-target lesions were not done at week 32. |
Dataset2 |
---|
Row | STUDYID | DOMAIN | USUBJID | TRSEQ | TRGRPID | TRLNKGRP | TRLNKID | TRTESTCD | TRTEST | TRORRES | TRORRESU | TRSTRESC | TRSTRESN | TRSTRESU | TRSTAT | TRREASND | TRMETHOD | TREVAL | EPOCH | VISITNUM | VISIT | TRDTC | TRDY | 1 | EX33333 | TR | 90003 | 1 | TARGET | A1 | T01 | LDIAM | Longest Diameter | 16 | mm | 16 | 16 | mm |
|
| CT SCAN | INVESTIGATOR | SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 2 | EX33333 | TR | 90003 | 2 | TARGET | A1 | T02 | LDIAM | Longest Diameter | 28 | mm | 28 | 28 | mm |
|
| CT SCAN | INVESTIGATOR | SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 3 | EX33333 | TR | 90003 | 3 | TARGET | A1 | T03 | LDIAM | Longest Diameter | 41 | mm | 41 | 41 | mm |
|
| CT SCAN | INVESTIGATOR | SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 4 | EX33333 | TR | 90003 | 4 | TARGET | A1 | T04 | LDIAM | Longest Diameter | 82 | mm | 83 | 83 | mm |
|
| CT SCAN | INVESTIGATOR | SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 5 | EX33333 | TR | 90003 | 5 | TARGET | A1 |
| SUMLDIAM | Sum of Longest Diameter | 167 | mm | 168 | 168 | mm |
|
|
| INVESTIGATOR | SCREEN | 1 | SCREENING |
|
| 6 | EX33333 | TR | 90003 | 6 | NON-TARGET | A1 | NT01 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| CT SCAN | INVESTIGATOR | SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 7 | EX33333 | TR | 90003 | 7 | NON-TARGET | A1 | NT02 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| CT SCAN | INVESTIGATOR | SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 8 | EX33333 | TR | 90003 | 8 | NON-TARGET | A1 | NT03 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| SCINTIGRAPHY | INVESTIGATOR | SCREEN | 1 | SCREENING | 2007-01-01 | 1 | 9 | EX33333 | TR | 90003 | 9 | TARGET | A2 | T01 | LDIAM | Longest Diameter | 10 | mm | 10 | 10 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 10 | EX33333 | TR | 90003 | 10 | TARGET | A2 | T02 | LDIAM | Longest Diameter | 20 | mm | 20 | 20 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 11 | EX33333 | TR | 90003 | 11 | TARGET | A2 | T03 | LDIAM | Longest Diameter | 30 | mm | 30 | 30 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 12 | EX33333 | TR | 90003 | 12 | TARGET | A2 | T04 | LDIAM | Longest Diameter | 65 | mm | 65 | 65 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 13 | EX33333 | TR | 90003 | 13 | TARGET | A2 |
| SUMLDIAM | Sum of Longest Diameter | 125 | mm | 125 | 125 | mm |
|
|
| INVESTIGATOR | TREATMENT | 3 | WEEK 8 |
|
| 14 | EX33333 | TR | 90003 | 14 | NON-TARGET | A2 | NT01 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 15 | EX33333 | TR | 90003 | 15 | NON-TARGET | A2 | NT02 | TUMSTATE | Tumor State | ABSENT |
| ABSENT |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 16 | EX33333 | TR | 90003 | 16 | NON-TARGET | A2 | NT03 | TUMSTATE | Tumor State |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | SCINTIGRAPHY | INVESTIGATOR | TREATMENT | 3 | WEEK 8 |
|
| 17 | EX33333 | TR | 90003 | 17 | TARGET | A3 | T01 | LDIAM | Longest Diameter | TOO SMALL TO MEASURE | mm | 5 | 5 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 18 | EX33333 | TR | 90003 | 18 | TARGET | A3 | T02 | LDIAM | Longest Diameter | 12 | mm | 12 | 12 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 19 | EX33333 | TR | 90003 | 19 | TARGET | A3 | T03 | LDIAM | Longest Diameter | 15 | mm | 15 | 15 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 20 | EX33333 | TR | 90003 | 20 | TARGET | A3 | T04 | LDIAM | Longest Diameter | 40 | mm | 40 | 40 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 21 | EX33333 | TR | 90003 | 21 | TARGET | A3 |
| SUMLDIAM | Sum of Longest Diameter | 72 | mm | 72 | 72 | mm |
|
|
| INVESTIGATOR | TREATMENT | 5 | WEEK 16 |
|
| 22 | EX33333 | TR | 90003 | 22 | NON-TARGET | A3 | NT01 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 23 | EX33333 | TR | 90003 | 23 | NON-TARGET | A3 | NT02 | TUMSTATE | Tumor State | ABSENT |
| ABSENT |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 24 | EX33333 | TR | 90003 | 24 | NON-TARGET | A3 | NT03 | TUMSTATE | Tumor State |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | SCINTIGRAPHY | INVESTIGATOR | TREATMENT | 5 | WEEK 16 |
|
| 25 | EX33333 | TR | 90003 | 25 | TARGET | A4 | T01 | LDIAM | Longest Diameter | 0 | mm | 0 | 0 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 7 | WEEK 24 | 2009-06-19 | 168 | 26 | EX33333 | TR | 90003 | 26 | TARGET | A4 | T02 | LDIAM | Longest Diameter | 15 | mm | 15 | 15 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 7 | WEEK 24 | 2009-06-19 | 168 | 27 | EX33333 | TR | 90003 | 27 | TARGET | A4 | T03 | LDIAM | Longest Diameter | 5 | mm | 5 | 5 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 7 | WEEK 24 | 2009-06-19 | 168 | 28 | EX33333 | TR | 90003 | 28 | TARGET | A4 | T04 | LDIAM | Longest Diameter | 36 | mm | 36 | 36 | mm |
|
| CT SCAN | INVESTIGATOR | TREATMENT | 7 | WEEK 24 | 2009-06-19 | 168 | 29 | EX33333 | TR | 90003 | 29 | TARGET | A4 |
| SUMLDIAM | Sum of Longest Diameter | 56 | mm | 56 | 56 | mm |
|
|
| INVESTIGATOR | TREATMENT | 7 | WEEK 24 |
|
| 30 | EX33333 | TR | 90003 | 30 | NON-TARGET | A4 | NT01 | TUMSTATE | Tumor State |
|
|
|
|
| NOT DONE | NOT EVALUABLE | CT SCAN | INVESTIGATOR | TREATMENT | 7 | WEEK 24 | 2009-06-19 | 168 | 31 | EX33333 | TR | 90003 | 31 | NON-TARGET | A4 | NT02 | TUMSTATE | Tumor State | ABSENT |
| ABSENT |
|
|
|
| CT SCAN | INVESTIGATOR | TREATMENT | 7 | WEEK 24 | 2009-06-19 | 168 | 32 | EX33333 | TR | 90003 | 32 | NON-TARGET | A4 | NT03 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
|
|
| SCINTIGRAPHY | INVESTIGATOR | TREATMENT | 7 | WEEK 24 | 2009-06-26 | 175 | 33 | EX33333 | TR | 90003 | 33 | TARGET | A5 | T01 | LDIAM | Longest Diameter |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | CT SCAN | INVESTIGATOR | TREATMENT | 9 | WEEK 32 |
|
| 34 | EX33333 | TR | 90003 | 34 | TARGET | A5 | T02 | LDIAM | Longest Diameter |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | CT SCAN | INVESTIGATOR | TREATMENT | 9 | WEEK 32 |
|
| 35 | EX33333 | TR | 90003 | 35 | TARGET | A5 | T03 | LDIAM | Longest Diameter |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | CT SCAN | INVESTIGATOR | TREATMENT | 9 | WEEK 32 |
|
| 36 | EX33333 | TR | 90003 | 36 | TARGET | A5 | T04 | LDIAM | Longest Diameter |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | CT SCAN | INVESTIGATOR | TREATMENT | 9 | WEEK 32 |
|
| 37 | EX33333 | TR | 90003 | 37 | NON-TARGET | A5 | NT01 | TUMSTATE | Tumor State |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | CT SCAN | INVESTIGATOR | TREATMENT | 9 | WEEK 32 |
|
| 38 | EX33333 | TR | 90003 | 38 | NON-TARGET | A5 | NT02 | TUMSTATE | Tumor State |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | CT SCAN | INVESTIGATOR | TREATMENT | 9 | WEEK 32 |
|
| 39 | EX33333 | TR | 90003 | 39 | NON-TARGET | A5 | NT03 | TUMSTATE | Tumor State |
|
|
|
|
| NOT DONE | SCAN NOT PERFORMED | SCINTIGRAPHY | INVESTIGATOR | TREATMENT | 9 | WEEK 32 |
|
| |
|
4.4 Example 4: RECIST 1.1 example to show independent assessor response (RS) data and the underlying tumor identification (TU), and tumor results (TR) data. This example shows the use of the acceptance flag to identify records when multiple assessments are performed by independent assessors (Radiologist 1 and Radiologist 2) for the same timepoint.
4.4.1 RS Domain Model
The rs.xpt table below shows the terminology used to implement RECIST 1.1 in the RS domain. This example shows the data for one subject collected at week 8 and week 16.
This example shows the use of the acceptance flag (RSACPTFL) to identify records when multiple assessments are performed by independent assessors (Radiologist 1 and Radiologist 2) for the same timepoint, i.e., RSACPTFL RSACPTFL indicates the "selected" response when more than read is performed. In some instances, a vendor may only supply a single response record for the "selected" response either because there was adjudication or the vendor would select the appropriate response. This alternative approach would result in only the "selected" response records in the RS domain. It is It is not expected that the RSACPTFL flag would be populated by the sponsor. That type of record selection or censoring would by be part of the analysis dataset.
...
The tu.xpt table below shows the terminology used to implement RECIST 1.1 in the TU domain. The example shows the use of the acceptance flag (TUACPTFL) to identify records when multiple assessments are performed by independent assessors (Radiologist 1 and Radiologist 2) for the same timepoint using RECIST 1.1. The acceptance flag indicates records which are chosen by an adjudicator. Not all sponsors have both sets of independent reviews exported, i.e., only the accepted records are transferred. It is not expected that the TUACPTFL flag would be populated by the sponsor. That type of record selection or censoring would by part be part of the analysis dataset. The tumor identifier is in TULNKID and matches TRLNKIDs in the TR Domain.
...
The tr.xpt table below shows the terminology used to implement RECIST 1.1 in the TR domain. This example shows the use of the acceptance flag to identify records when multiple assessments are performed by independent assessors (Radiologist 1 and Radiologist 2) for the same timepoint using RECIST 1.1. It is not expected that the TUACPTFL flag would be populated by the sponsor. That type of record selection or censoring would by part be part of the analysis dataset.
This examples example shows that situation where the Independent Assessor provided the summary values for Target for Target lesions as a group (TRGRPID = "TARGET"). The TRTESTCDs used for the assessments are: "SUMDIAM", "ACNSD", "PCBSD" and "PCNSD". Note Note that the sponsor should not derived derive these values if they were not part of the data capture or not provided in the transfer from the vendorthe vendor.
Dataset wrap |
---|
|
Rowcaps |
---|
Rows 1-32: Show that two radiologists independently reviewed the scans. TRLNKGRP has values "R1-A2" and "R1-A3" to indicate the assessments by "RADIOLOGIST 1" which are linked to the results determine by "RADIOLOGIST 1" in RS. Likewise, the values "R2-A2" and "R2-A3" to indicate the assessments by "RADIOLOGIST 2" which are linked to the results determine by "RADIOLOGIST 2" in RS. Rows 17-32: Show that the results provided by "RADIOLOGIST 2" are the accepted records (TRACPTFL). The accepted record flags are per the data transfer from the independent reviewer. |
Dataset2 |
---|
Row | STUDYID | DOMAIN | USUBJID | TRSEQ | TRGRPID | TRLNKGRP | TRLNKID | TRTESTCD | TRTEST | TRORRES | TRORRESU | TRSTRESC | TRSTRESN | TRSTRESU | TRNAM | TRMETHOD | TREVAL | TREVALID | TRACPTFL | EPOCH | VISITNUM | VISIT | TRDTC | TRDY | 1 | EX44444 | TR | 90004 | 1 | TARGET | R1-A1 | R1-T01 | LDIAM | Longest Diameter | 15 | mm | 15 | 15 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 2 | EX44444 | TR | 90004 | 2 | TARGET | R1-A1 | R1-T02 | LDIAM | Longest Diameter | 25 | mm | 25 | 25 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 3 | EX44444 | TR | 90004 | 3 | TARGET | R1-A1 |
| SUMLDIAM | Sum of Longest Diameter | 40 | mm | 40 | 40 | mm | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 4 | EX44444 | TR | 90004 | 4 | NON-TARGET | R1-A1 | R1-NT01 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
| RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 5 | EX44444 | TR | 90004 | 5 | TARGET | R1-A2 | R1-T01 | LDIAM | Longest Diameter | 10 | mm | 10 | 10 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 6 | EX44444 | TR | 90004 | 6 | TARGET | R1-A2 | R1-T02 | LDIAM | Longest Diameter | 25 | mm | 25 | 25 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 7 | EX44444 | TR | 90004 | 7 | TARGET | R1-A2 |
| SUMLDIAM | Sum of Longest Diameter | 35 | mm | 35 | 35 | mm | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 3 | WEEK 8 |
|
| 8 | EX44444 | TR | 90004 | 8 | TARGET | R1-A2 |
| PCBSLD | Percent Change From Baseline in Sum of Longest Diameter | -13 | % | -13 | -13 | % | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 3 | WEEK 8 |
|
| 9 | EX44444 | TR | 90004 | 9 | TARGET | R1-A2 |
| PCNSLD | Percent Change From Nadir in Sum of Longest Diameter | -13 | % | -13 | -13 | % | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 3 | WEEK 8 |
|
| 10 | EX44444 | TR | 90004 | 10 | NON-TARGET | R1-A2 | R1-NT01 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
| RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 11 | EX44444 | TR | 90004 | 11 | TARGET | R1-A3 | R1-T01 | LDIAM | Longest Diameter | 5 | mm | 5 | 5 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 12 | EX44444 | TR | 90004 | 12 | TARGET | R1-A3 | R1-T02 | LDIAM | Longest Diameter | 10 | mm | 10 | 10 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 13 | EX44444 | TR | 90004 | 13 | TARGET | R1-A3 |
| SUMLDIAM | Sum of Longest Diameter | 15 | mm | 15 | 15 | mm | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 5 | WEEK 16 |
|
| 14 | EX44444 | TR | 90004 | 14 | TARGET | R1-A3 |
| PCBSLD | Percent Change From Baseline in Sum of Longest Diameter | -63 | % | -63 | -63 | % | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 5 | WEEK 16 |
|
| 15 | EX44444 | TR | 90004 | 15 | TARGET | R1-A3 |
| PCNSLD | Percent Change From Nadir in Sum of Longest Diameter | -57 | % | -57 | -57 | % | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 5 | WEEK 16 |
|
| 16 | EX44444 | TR | 90004 | 16 | NON-TARGET | R1-A3 | R1-NT01 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
| RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 1 |
| TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 17 | EX44444 | TR | 90004 | 17 | TARGET | R2-A1 | R2-T01 | LDIAM | Longest Diameter | 25 | mm | 25 | 25 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 18 | EX44444 | TR | 90004 | 18 | TARGET | R2-A1 | R2-T02 | LDIAM | Longest Diameter | 20 | mm | 20 | 20 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 19 | EX44444 | TR | 90004 | 19 | TARGET | R2-A1 |
| SUMLDIAM | Sum of Longest Diameter | 45 | mm | 45 | 45 | mm | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | SCREEN | 1 | SCREENING |
|
| 20 | EX44444 | TR | 90004 | 20 | NON-TARGET | R2-A1 | R2-NT01 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
| RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | SCREEN | 1 | SCREENING | 2007-01-02 | 1 | 21 | EX44444 | TR | 90004 | 21 | TARGET | R2-A2 | R2-T01 | LDIAM | Longest Diameter | 10 | mm | 10 | 10 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 22 | EX44444 | TR | 90004 | 22 | TARGET | R2-A2 | R2-T02 | LDIAM | Longest Diameter | 8 | mm | 8 | 8 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 23 | EX44444 | TR | 90004 | 23 | TARGET | R2-A2 |
| SUMLDIAM | Sum of Longest Diameter | 18 | mm | 18 | 18 | mm | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 3 | WEEK 8 |
|
| 24 | EX44444 | TR | 90004 | 24 | TARGET | R2-A2 |
| PCBSLD | Percent Change From Baseline in Sum of Longest Diameter | -60 | % | -60 | -60 | % | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 3 | WEEK 8 |
|
| 25 | EX44444 | TR | 90004 | 25 | TARGET | R2-A2 |
| PCNSLD | Percent Change From Nadir in Sum of Longest Diameter | -60 | % | -60 | -60 | % | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 3 | WEEK 8 |
|
| 26 | EX44444 | TR | 90004 | 26 | NON-TARGET | R2-A2 | R2-NT01 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
| RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 3 | WEEK 8 | 2007-02-27 | 56 | 27 | EX44444 | TR | 90004 | 27 | TARGET | R2-A3 | R2-T01 | LDIAM | Longest Diameter | 15 | mm | 15 | 15 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 28 | EX44444 | TR | 90004 | 28 | TARGET | R2-A3 | R2-T02 | LDIAM | Longest Diameter | TOO SMALL TO MEASURE | mm | 5 | 5 | mm | RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | 29 | EX44444 | TR | 90004 | 29 | TARGET | R2-A3 |
| SUMLDIAM | Sum of Longest Diameter | 20 | mm | 20 | 20 | mm | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 5 | WEEK 16 |
|
| 30 | EX44444 | TR | 90004 | 30 | TARGET | R2-A3 |
| PCBSLD | Percent Change From Baseline in Sum of Longest Diameter | -56 | % | -56 | -56 | % | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 5 | WEEK 16 |
|
| 31 | EX44444 | TR | 90004 | 31 | TARGET | R2-A3 |
| PCNSLD | Percent Change From Nadir in Sum of Longest Diameter | 11 | % | 11 | 11 | % | RADIOL INC. |
| INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 5 | WEEK 16 |
|
| 32 | EX44444 | TR | 90004 | 32 | NON-TARGET | R2-A3 | R2-NT01 | TUMSTATE | Tumor State | PRESENT |
| PRESENT |
|
| RADIOL INC. | CT SCAN | INDEPENDENT ASSESSOR | RADIOLOGIST 2 | Y | TREATMENT | 5 | WEEK 16 | 2007-04-24 | 112 | |
|
...
The tu.xpt table below shows the terminology used to implement RECIST 1.1 in the TU domain. This example shows the data for one subject at screening and at weeks 36 and 44 where new lesions are identified. In this example, lymph nodes are selected as target tumors. In RECIST 1.1, target lymph node tumors are measured in the short axis longest perpendicular (TRTESTCD = "LPERP" and TRTEST = "Longest Perpendicular"). The image identifier is in TUREFID and matches a PRREFID in the PR Domain.
...
The example below shows measurements (i.e., short axislongest perpendicular) of lymph nodes as well as measurements of other non-lymph node Target tumors (i.e., longest diameter). In this example, when TRTEST = "Lymph Node State" and TRORRES = "NON-PATHOLOGICAL", it indicates that the lymph node lesion was not pathological, i.e. the diameter has reduced below 10mm. The assessment of a lymph node tumor is less than 10mm. When a target lymph node tumor has longest perpendicular greater than or equal to 10mm, the assessment is represented with TRTEST = "Lymph Node State" and TRORRES = "NON-PATHOLOGICAL" when that all target lymph node lesions have short axis less than 10mm or TRORRES = "PATHOLOGICAL" when at least one target lymph node tumor has short axis greater than or equal to 10mm.
This examples shows that situation where the Independent Assessor provided the summary values for Target lesions as a group (TRGRPID = "TARGET"). The TRTESTCDs used for the assessments are: "SUMDIAM", "SUMNLNLD", "ACNSD", "PCBSD" and "PCNSD".
...